<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01811004</url>
  </required_header>
  <id_info>
    <org_study_id>CYN12-GS-HH01</org_study_id>
    <nct_id>NCT01811004</nct_id>
  </id_info>
  <brief_title>Evaluation of 1440nm Laser vs. Botulinum Toxin or miraDry® Microwave For Treatment of Axillary Hyperhidrosis</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cynosure, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cynosure, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Purpose of the study is to evaluate the 1440nm Laser Assisted Selective Photothermolysis
      vs. Botulinum Toxin or miraDry® Microwave Thermolysis For Treatment of Axillary
      Hyperhidrosis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of Amount of Sweat Produced</measure>
    <time_frame>up to 12 months post treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subject biopsy sampling</measure>
    <time_frame>Baseline and 9 months post treatment</time_frame>
    <description>Histological examination of tissue samples pre-treatment and 9 months post treatment to assess safety and tolerability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction Questionnaires</measure>
    <time_frame>up to 12 months post treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Hyperhidrosis</condition>
  <arm_group>
    <arm_group_label>Botox®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Botox®</description>
  </arm_group>
  <arm_group>
    <arm_group_label>miraDry®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>miraDry®</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nd: YAG laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nd: YAG laser 1440nm</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>miraDry</intervention_name>
    <description>miraDry</description>
    <arm_group_label>miraDry®</arm_group_label>
    <arm_group_label>Nd: YAG laser</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nd:YAG Laser</intervention_name>
    <description>Nd:YAG 1440 nm Laser</description>
    <arm_group_label>Botox®</arm_group_label>
    <arm_group_label>miraDry®</arm_group_label>
    <arm_group_label>Nd: YAG laser</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Botox®</intervention_name>
    <description>Botox®</description>
    <arm_group_label>Botox®</arm_group_label>
    <arm_group_label>Nd: YAG laser</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A healthy non-smoking male or female between 18-70 years of age

          -  Understand/accept obligation not to receive any other procedures in anatomical areas
             exhibiting axillary hyperhidrosis through 3 months prior to treatment

          -  Understand and accept the obligation and is logistically able to present for all
             scheduled follow-up visits

          -  Clinically diagnosed for primary hyperhidrosis of the axilla.

          -  A self-assessed HDSS score of three (3) or four (4) a. Gravimetric &gt;50mg/5min in each
             axilla

        Exclusion Criteria:

          -  Clinical diagnosis of secondary hyperhidrosis

          -  Uncontrolled systemic disease or infection

          -  Concurrent use of any hyperhidrosis treatments other than OTC antiperspirants or
             deodorants

          -  Receipt of Botox® or Dysport® within the past six months

          -  Patients who refuse to stop using OTC antiperspirants 24 hours prior to the day of
             surgery and each of the follow-up visits at 3 months and 6 months that Minors starch
             iodine tests may be performed.

          -  Patients using or having used within 7 days of baseline visit: cholinomimetic agents,
             anticholinergic agents, prescription antiperspirants, any herbal medicine treatments
             or any other treatments for hyperhidrosis except OTC antiperspirant or planning to use
             such agents during the course of the study.

          -  Any previous liposuction/liposculpture or any type of surgery for hyperhidrosis; OR
             any other types of treatments for hyperhidrosis in the area to be treated in the past
             6 months

          -  Has any other medical condition, that, in the investigator's opinion would interfere
             with the subject's participation in the study

          -  Is susceptible to light induced seizures or history of seizures

          -  Has a history of keloid formation

          -  Significant cardiovascular disease

          -  Bleeding disorders

          -  Anti-platelet and anticoagulant medication

          -  Sensitivity to lidocaine or epinephrine

          -  Pregnancy or planned pregnancy

          -  Existing neuromuscular disorders (myasthenia gravis, Eaton-Lambert Syndrome,
             amyotrophic lateral sclerosis)

          -  Electronic implants

          -  Subjects requiring supplemental oxygen

          -  Has therapies or medications which may interfere with the treatment (including
             medications causing photosensitivity

          -  Allergic to Keflex
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patricia Krantz</last_name>
    <role>Study Director</role>
    <affiliation>Cynosure, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sasaki Advanced Aesthetic Medical Center</name>
      <address>
        <city>Pasadena</city>
        <state>California</state>
        <zip>91105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 6, 2012</study_first_submitted>
  <study_first_submitted_qc>March 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2013</study_first_posted>
  <last_update_submitted>February 16, 2016</last_update_submitted>
  <last_update_submitted_qc>February 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperhidrosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>onabotulinumtoxinA</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

